Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan
· Delayed Price · Currency is TWD 23.60
+0.15 (0.64%)
Mar 10, 2026, 2:12 PM CST
Genomics BioSci & Tech. Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,699 | 1,391 | 1,507 | 1,257 | 1,126 | 1,117 | Upgrade
|
| Market Cap Growth | 23.75% | -7.69% | 19.84% | 11.67% | 0.78% | 50.20% | Upgrade
|
| Enterprise Value | 2,222 | 1,622 | 1,416 | 1,233 | 1,074 | 803 | Upgrade
|
| Last Close Price | 23.45 | 19.20 | 20.80 | 19.35 | 18.37 | 18.22 | Upgrade
|
| PE Ratio | - | - | - | 17.56 | 60.09 | 1805.00 | Upgrade
|
| PS Ratio | 2.79 | 2.88 | 3.80 | 3.00 | 2.89 | 2.52 | Upgrade
|
| PB Ratio | 2.77 | 2.17 | 1.97 | 1.59 | 1.66 | 1.23 | Upgrade
|
| P/TBV Ratio | 3.21 | 2.56 | 1.97 | 1.60 | 1.66 | 1.67 | Upgrade
|
| EV/Sales Ratio | 3.65 | 3.36 | 3.57 | 2.94 | 2.75 | 1.81 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 1319.50 | 21.29 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 121.76 | Upgrade
|
| EV/FCF Ratio | -9.79 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.93 | 0.79 | 0.37 | 0.29 | 0.13 | 0.13 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 18.95 | 2.84 | Upgrade
|
| Net Debt / Equity Ratio | 0.73 | 0.42 | 0.04 | -0.11 | -0.03 | -0.50 | Upgrade
|
| Net Debt / EBITDA Ratio | -10.00 | -3.15 | -0.62 | 16.29 | -25.75 | -12.12 | Upgrade
|
| Net Debt / FCF Ratio | -1.96 | -0.88 | -0.12 | 0.77 | 0.17 | 7.43 | Upgrade
|
| Asset Turnover | - | 0.39 | 0.35 | 0.43 | 0.39 | 0.43 | Upgrade
|
| Inventory Turnover | - | 2.92 | 4.75 | 7.47 | 12.45 | 15.88 | Upgrade
|
| Quick Ratio | 0.65 | 0.98 | 2.53 | 2.47 | 2.02 | 3.46 | Upgrade
|
| Current Ratio | 1.28 | 1.61 | 3.23 | 2.95 | 2.66 | 3.80 | Upgrade
|
| Return on Equity (ROE) | - | -33.47% | -21.62% | 9.75% | 1.52% | -0.18% | Upgrade
|
| Return on Assets (ROA) | - | -7.03% | -4.54% | -2.12% | -1.78% | 0.40% | Upgrade
|
| Return on Invested Capital (ROIC) | -9.96% | -16.44% | -10.94% | -4.89% | -5.17% | 1.70% | Upgrade
|
| Return on Capital Employed (ROCE) | -11.20% | -14.40% | -8.30% | -3.50% | -3.80% | 0.70% | Upgrade
|
| Earnings Yield | -4.92% | -16.04% | -11.15% | 5.69% | 1.66% | 0.06% | Upgrade
|
| FCF Yield | -13.36% | -21.95% | -16.34% | -9.16% | -10.78% | -5.51% | Upgrade
|
| Dividend Yield | - | - | - | 0.51% | - | - | Upgrade
|
| Payout Ratio | - | - | - | 0.00% | 0.19% | 11222.94% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -1.89% | -11.87% | -5.12% | -0.23% | 0.47% | Upgrade
|
| Total Shareholder Return | -0.01% | -1.89% | -11.87% | -4.62% | -0.23% | 0.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.